The Discounted Cash Flow (DCF) valuation of Harvard Bioscience Inc (HBIO) is 3.24 USD. With the latest stock price at 2.40 USD, the upside of Harvard Bioscience Inc based on DCF is 35.0%.
| Range | Selected | |
| WACC / Discount Rate | 7.8% - 10.5% | 9.2% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 2.05 - 6.44 | 3.24 |
| Upside | -14.7% - 168.2% | 35.0% |